Methyldopa Tablet
Short Description
Product Composition & Available StrengthsWe supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
|
Full Description
Methyldopa TabletMethyldopa Tablets IP / BP / USP (250 mg / 500 mg)Centrally Acting Anti-Hypertensive Maternal TherapeuticHealthy Life Pharma Private Limited, alongside our specialized global export and marketing division Healthy Inc, is a premier Indian manufacturer, CDMO partner, and wholesale exporter of advanced maternal-fetal health, gynecology, and cardiovascular therapeutics. We manufacture ultra-high-purity, kinetically stable Methyldopa Tablets within our state-of-the-art, WHO–GMP certified solid dosage manufacturing installations. As a primary, safe therapeutic choice for gestational cardiovascular disorders, this formulation acts as a massive-volume strategic export to maternity hospital cooperatives, state healthcare distribution pipelines, national health ministry procurement tenders, and international digital B2B pharmaceutical marketplaces across Africa, the CIS region, LATAM, and South-East Asia. Product OverviewThis formulation operates as a "Central Sympathetic Outflow Suppressor." It ensures maternal and fetal safety by modifying neurological vascular signals in the brainstem, safely lowering systemic blood pressure without reducing uterine or placental perfusion.
Product Composition & Available StrengthsWe supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
Technical & Logistics Specifications
Advanced Manufacturing Integrity & Quality Controls
Primary Indications
Usage Instructions
Safety Warning: CRITICAL FIRST-LINE MATERNAL ANTI-HYPERTENSIVE. For Obstetrician/Physician Supervision Only. Sedation Warning: Centrally induces transient drowsiness, dizziness, or orthostatic hypotension; advise patients to move physically slow during initial titration windows. Hepatic Care Note: Monitor liver parameters chemically ($ALT$/$AST$) during the first 6 to 12 weeks of therapy to check for rare drug-induced hepatic hypersensitivity. Contraindications: Absolute contraindication in patients presenting with active hepatic disease (acute hepatitis, active cirrhosis), monoamine oxidase inhibitor ($MAOI$) co-administration, or a known history of severe hypersensitivity to methyldopa. Global CDMO Services & Wholesale Supply ChainHealthy Life Pharma Private Limited and Healthy Inc provide comprehensive, internationally validated Third-Party Contract Manufacturing (CDMO Services) and high-volume private label export supply for the entire Methyldopa dosage spectrum. Whether you are executing a high-volume procurement contract for an African National Maternal and Child Health Tender, supplying a specialized public hospital infrastructure across the CIS region, or injecting premium inventory into an international digital B2B Pharmaceutical Marketplace across Southeast Asia or LATAM, we handle all required technical documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product - COPP, Certificates of Analysis - COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for seamless regulatory clearance. Commercial & Bulk Procurement Inquiries:
|
Request a Quote
Contact our export team for product availability, packaging and documentation.
For professional procurement information only. Consult a qualified healthcare professional before using any medicine.
Rate this Product
Frequently Asked Questions
How can I request a quote for this product?
Use the enquiry form on this page or contact our export team by email or WhatsApp.
How can I confirm packaging and documentation?
Contact our export team to confirm product availability, packaging and documentation.

Candesartan Tablets
Diltiazem Tablets
Imidapril Hydrochloride Tablets
Indapamide Tablets
Lisinopril Tablet
Nicoumalone Tablet
Nifedipine Tablet
Phenobarbital Tablets